Head-to-head comparison of pembrolizumab-axitinib versus pembrolizumab-lenvatinib in metastatic RCC: Real world data from the Canadian Kidney Cancer Information System (CKCis) database.

Alexandre da Silva Faco, Ramy Saleh, Mohammad Hassan Hodroj et al.|Journal of Clinical Oncology|2026

Cited by 0